Brief: CLSA Premium Sees Unaudited Net Profit Of HK$5.2 Million For Six Months
July 24 (Reuters) - CLSA Premium 6877.HK :
* SEES UNAUDITED NET PROFIT OF APPROXIMATELY HK$5.2 MILLION
FOR
SIX MONTHS
* EXPECTED RESULT DUE TO GROWTH OF HEALTHCARE PRODUCTS
BUSINESS
IN FIRST HALF OF 2023
* TRADING IN CO'S SHARES ON STOCK EXCHANGE WILL REMAIN
SUSPENDED
PENDING FULFILMENT OF RESUMPTION GUIDANCE
Further company coverage: 6877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Top Eminent Healthcare
See all newsBrief: Top Eminent Healthcare Ordered To Pay Banclogix HK$2.5 Million Termination Fee, Others
Brief: Top Eminent Healthcare Says Proposed Acquisition Of Top Eminent II Limited Lapses
Brief: Top Eminent Healthcare Posts FY Total Income Hk$106.9 Million
Brief: Top Eminent Healthcare To Acquire Top Eminent II
Brief: Top Eminent Healthcare Expects Consolidated Net Loss Attributable Of HK$7.1 Million For 2025